Previous
SmallCapReview Introduces Biophan Technologies (BIPH)
Added: (Fri Sep 23 2005)
SmallCapReview.com ( www.SmallCapReview.com), a leading small-cap stock information site, introduces Biophan Technologies (OTC BB: BIPH) to its database of subscribers and its website audience.
Biophan develops and markets cutting-edge technologies designed to make biomedical devices safe and image compatible with the magnetic resonance imaging (MRI) environment. The Company develops technologies that enable implanted medical systems such as pacemakers, interventional surgical devices such as catheters and guidewires, and devices such as stents to be safely and effectively imaged under MRI. Biophan is developing these same technologies to provide new MRI contrast agents. Other applications include drug delivery and power systems derived from body heat.
Four Biophan technologies include advances in nanotechnology and thin film coatings. Committed to growth through innovation and developmental leadership, Biophan and its licensors now hold a total of 144 U.S. patents, licenses, or applications.
To learn more about Biophan Technologies please visit www.smallcapreview.com/biph.htm.
SmallCapReview.com news is a Free Newsletter sent to subscribers, highlighting select small-cap stocks. To sign-up visit www.smallcapreview.com/subscribe.htm. Features available at SmallCapReview.com include in-depth profiles of select Small-Cap and Penny Stocks, all-in-one message boards covering the top message board forums, an exhaustive research page, tech charts, and daily news on companies and trends in the small-cap market.
Forward Looking Statements
Except for the historical information contained herein, the matters discussed in this release may include certain forward-looking statements, which are intended to be covered by safe harbors. Investors are cautioned that all forward-looking statements involve risks and uncertainties including, without limitation, the factors detailed from time to time in company filings with the Securities and Exchange Commission. These factors could affect businesses and financial results in the future and could cause actual results to differ materially from plans and projections. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by the company or any other person that objectives and plans will be achieved. All forward-looking statements made in this release are based on information presently available. We assume no obligation to update any forward-looking statements, except as required by law.
Disclosure: No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. SmallCapReview.com may hold positions in securities mentioned herein, and may make purchases or sales in such securities featured on our website or within our reports. In order to be in full compliance with the Securities Act of 1933, Section 17(b), SmallCapReview.com will disclose in it's disclaimer, what, if any compensation was received for our efforts in researching, presenting and disseminating this information to our subscriber database and featuring the report on our website. SmallCapReview.com was compensated eleven thousand dollars in May of 2004 and an additional six thousand dollars in September 2005 for its efforts in presenting the Biophan Technologies profile on its website and distributing it to its database of subscribers. Readers are encouraged to view the full disclaimer at www.smallcapreview.com/biph.htm.